¼Ö·ç¼Ç ÀÎÅÚ¸®Àü½º ¹× Ä¿³ØÆ¼ºñƼ Çâ»óÀ¸·Î 2027³â±îÁö ¼ºÀå ÀáÀç·Â Çâ»ó
ÀÌ º¸°í¼´Â Frost & SullivanÀÇ ½ÃÀå Á¶»ç º¸°í¼·Î È£Èí±â ±â±â ½ÃÀåÀ» ºÐ¼®ÇÏ¿© ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, ¼ºÀå·ü, µ¿Çâ, ½ÃÀå ÃËÁø ¹× ¾ïÁ¦¿äÀÎ µîÀ» ´Ù·é ½ÃÀå Á¶»ç º¸°í¼ÀÔ´Ï´Ù. Á¶»ç ±âÁØ ¿¬µµ´Â 2023³â, ½ÃÀå ±Ô¸ð´Â 2020³âºÎÅÍ 2027³â±îÁöÀ̸ç, 2020³â¿¡´Â COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ È£Èí±â ±â±â ¼ö¿ä°¡ ±ÞÁõÇÏ¸é¼ ±âÁ¸ È£Èí±â ±â¼ú¿¡ ´Ù¾çÇÑ µµÀü°úÁ¦¸¦ ³ëÃâ½ÃÄ×½À´Ï´Ù. Áö³ 3³â µ¿¾È ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÆÄ¾ÇÇϰí ȯÀÚ Ä¡·á °³¼±À» À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» µµÀÔÇϱâ À§ÇØ ¸¹Àº ÅõÀÚ°¡ ÀÌ·ç¾îÁ³½À´Ï´Ù. ±â±â ¿¬°á¼º Çâ»ó°ú ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀº È£Èí±â ±â±â ½ÃÀå¿¡¼ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ´Â ÁÖ¿ä ±â¼úÀÔ´Ï´Ù. À̹ø Á¶»ç¿¡¼´Â ÀÌ·¯ÇÑ È£Èí±â Ä¡·áÀÇ º¯È¿Í ±â¾÷ÀÌ °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ Ãß±¸ÇÒ ¼ö ÀÖ´Â °¡Àå Áß¿äÇÑ ±âȸ¸¦ »ìÆìº¾´Ï´Ù.
ÀÌ Á¶»ç¿¡¼ ´Ù·ç´Â È£Èí±â ±â±â À¯Çü¿¡´Â ±âµµ ¾ç¾Ð±â(PAP) ÀåÄ¡, ÀΰøÈ£Èí±â, Ä¡·á¿ë È£Èí±â ±â±â, È£Èí ¸ð´ÏÅ͸µ ÀåÄ¡, ¼Ò¸ðǰ ¹× ¾×¼¼¼¸® µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ¿¬±¸´Â º´¿ø, ÀçÅÃÀÇ·á, ¿Ü·¡È¯ÀÚ È¯°æ, Áø·á¼Ò µî ´Ù¾çÇÑ È£Èí±â ±â±â ÃÖÁ¾»ç¿ëÀÚ¸¦ ½Äº°ÇÕ´Ï´Ù. Áö¿ª ¹üÀ§´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Ä«¸®ºêÇØ, Áßµ¿, ºÏ¾ÆÇÁ¸®Ä«, ³²¹Ì(MENASA)¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ¿¬±¸´Â µ¶ÀÚµéÀÌ È£Èí±â ±â±â ½ÃÀåÀÇ ÁÖ¿ä Áö¿ª, ÁÖ¿ä ±âȸ ¹× µ¿ÇâÀ» ÆÄ¾ÇÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.
¸ñÂ÷
Àü·«Àû ¿øÄ¢
- ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö´Â°¡?
- The Strategic Imperative 8(TM)
- È£Èí±â ±â±â ¾÷°èÀÇ Àü·«Àû ¿øÄ¢ÀÇ ¿µÇâ
- ¼ºÀå ±âȸ°¡ Growth Pipeline Engine(TM)À» ÃËÁø
¼ºÀå ±âȸ ºÐ¼®
- ºÐ¼® ¹üÀ§
- ¼¼ºÐÈ
- Áö¿ªº° ÁÖ¿ä °æÀï»ç
- Á¦Ç° À¯Çüº° ÁÖ¿ä °æÀï»ç
- ¼ºÀå ÁöÇ¥
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ¿¹Ãø °¡Á¤
- ¸ÅÃâ ¿¹Ãø
- Á¦Ç°º° ¸ÅÃâ ¿¹Ãø
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ ¿¹Ãø
- Áö¿ªº° ¸ÅÃâ ¿¹Ãø
- ¸ÅÃâ°ú ¿¹Ãø ºÐ¼®
- °¡°Ý µ¿Çâ°ú ¿¹Ãø ºÐ¼®
- °æÀï ȯ°æ
- ¸ÅÃâ Á¡À¯À²
- ¸ÅÃâ Á¡À¯À² ºÐ¼®
- ±â¾÷ ¸ÅÇÎ
Á¦Ç° ºÐ¼®
- PAP µð¹ÙÀ̽º
- ÀΰøÈ£Èí±â
- »ê¼Ò¹ß»ý±â
- ÈíÀÔ±â¿Í ³×ºí¶óÀÌÀú
- ±âŸ Ä¡·á ±â±â
- ¸ð´ÏÅ͸µ ±â±â
È£Èí±â ÄÉ¾î µ¿Çâ
- È£Èí±â ÄÉ¾î °æ·Î °úÁ¦
- È£Èí±â ÄɾîÀÇ Ä¿³ØÆ¼µå µð¹ÙÀ̽º
- È£Èí±â ÄɾîÀÇ ÀΰøÁö´É
- ÀçÅà ȣÈí±â Äɾî
- È£Èí±â ÄÉ¾î »óȲ º¯È
- È£Èí±â ±â±â : ·»Å»°ú ±¸ÀÔ
¼ºÀå ±âȸ ºÐ¼® : ºÏ¹Ì
- ¼ºÀå ÁöÇ¥
- ¸ÅÃâ ¿¹Ãø
- Á¦Ç°º° ¸ÅÃâ ¿¹Ãø
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ ¿¹Ãø
- ¿¹Ãø ºÐ¼®
¼ºÀå ±âȸ ºÐ¼® : À¯·´
- ¼ºÀå ÁöÇ¥
- ¸ÅÃâ ¿¹Ãø
- Á¦Ç°º° ¸ÅÃâ ¿¹Ãø
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ ¿¹Ãø
- ¿¹Ãø ºÐ¼®
¼ºÀå ±âȸ ºÐ¼® : ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¼ºÀå ÁöÇ¥
- ¸ÅÃâ ¿¹Ãø
- Á¦Ç°º° ¸ÅÃâ ¿¹Ãø
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ ¿¹Ãø
- ¿¹Ãø ºÐ¼®
¼ºÀå ±âȸ ºÐ¼® : ¶óƾ¾Æ¸Þ¸®Ä«, Ä«¸®ºêÇØ ±¹°¡, MENASA
- ¼ºÀå ÁöÇ¥
- ¸ÅÃâ ¿¹Ãø
- Á¦Ç°º° ¸ÅÃâ ¿¹Ãø
- ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ ¿¹Ãø
- ¿¹Ãø ºÐ¼®
¼ºÀå ±âȸ À¯´Ï¹ö½º
- ¼ºÀå ±âȸ 1 : ½º¸¶Æ® µð¹ÙÀ̽º¿Í Ä¿³ØÆ¼µå µð¹ÙÀ̽º
- ¼ºÀå ±âȸ 2 : ¿ø°Ý ¸ð´ÏÅ͸µ°ú ¿ø°ÝÀÇ·á
- ¼ºÀå ±âȸ 3 : AI
- ¼ºÀå ±âȸ 4 : ÷´Ü ÀΰøÈ£Èí±â
´ÙÀ½ ½ºÅÜ
- ´ÙÀ½ ½ºÅÜ
- ¿Ö FrostÀΰ¡, ¿Ö Áö±ÝÀΰ¡?
- º°Áö ¸®½ºÆ®
- ¸éÃ¥»çÇ×
ksm
Increasing Solution Intelligence and Connectivity Boosts Growth Potential through 2027
This Frost & Sullivan study analyzes the respiratory devices market, including market estimates, forecasts, growth rates, trends, challenges, and drivers. The base year for the research is 2023 and market sizing is from 2020 to 2027. In 2020, the COVID-19 pandemic spurred sudden growth in demand for respiratory devices and exposed various challenges with existing respiratory technologies. In the last 3 years, many investments have been made to identify these challenges and introduce innovative solutions for improved patient care. Increasing device connectivity and remote monitoring functions are key technologies that have gained momentum in the respiratory devices market. This study covers such changes in respiratory care and the top opportunities companies can pursue to gain a competitive advantage.
The respiratory device types covered in the study include positive airway pressure (PAP) devices, ventilators, therapeutic respiratory devices, respiratory monitoring devices, and consumables and accessories. The study identifies various end users for respiratory devices including hospitals, home care, ambulatory settings, and clinics. Regional coverage includes North America, Europe, Asia-Pacific, Latin America, the Caribbean and MENASA (Middle East, North Africa, and South Asia). The study will help readers identify key regions, major opportunities, and trends in the respiratory devices market.
Table of Contents
Strategic Imperatives
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on the Respiratory Devices Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Opportunity Analysis
- Scope of Analysis
- Segmentation
- Key Competitors by Region
- Key Competitors by Product Type
- Growth Metrics
- Growth Drivers
- Growth Restraints
- Forecast Assumptions
- Revenue Forecast
- Revenue Forecast by Product
- Revenue Forecast by End User
- Revenue Forecast by Region
- Revenue Forecast Analysis
- Pricing Trends and Forecast Analysis
- Competitive Environment
- Revenue Share
- Revenue Share Analysis
- Company Mapping
Product Analysis
- Respiratory Devices: PAP Devices
- Respiratory Devices: Ventilators
- Respiratory Devices: Oxygen Concentrators
- Respiratory Devices: Inhalers and Nebulizers
- Respiratory Devices: Other Therapeutic Devices
- Respiratory Devices: Monitoring Devices
Respiratory Care Trends
- Respiratory Care Pathway Challenges
- Connected Devices in Respiratory Care
- Artificial Intelligence in Respiratory Care
- Home Respiratory Care
- Changing Respiratory Care Landscape
- Respiratory Devices: Rent vs. Buy
Growth Opportunity Analysis: North America
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Product
- Revenue Forecast by End User
- Forecast Analysis
Growth Opportunity Analysis: Europe
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Product
- Revenue Forecast by End User
- Forecast Analysis
Growth Opportunity Analysis: Asia-Pacific
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Product
- Revenue Forecast by End User
- Forecast Analysis
Growth Opportunity Analysis: Latin America, Caribbean, and MENASA
- Growth Metrics
- Revenue Forecast
- Revenue Forecast by Product
- Revenue Forecast by End User
- Forecast Analysis
Growth Opportunity Universe
- Growth Opportunity 1: Smart and Connected Devices
- Growth Opportunity 2: Remote Monitoring and Telemedicine
- Growth Opportunity 3: AI
- Growth Opportunity 4: Advanced Ventilators
Next Steps
- Your Next Steps
- Why Frost, Why Now?
- List of Exhibits
- Legal Disclaimer